Covid-19 Omicron boosters will reinvigorate injectables manufacturing
Pharmaceutical Technology
JULY 29, 2022
Pfizer completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted bivalent Covid-19 vaccine candidate, based on the BA.1 Bivalent vaccines work by stimulating an immune response against two different antigens, whereas monovalent vaccines only target one antigen. 1 sub-lineage on 19 July.
Let's personalize your content